John Cann, D.P.M.
| Appointed: |
1998 |
| Gender: |
Male |
| Languages: |
English |
Podiatry (Lorain)
Biographical Sketch
John Cann, DPM, is a Surgical Podiatrist at Cleveland Clinic Lorain, and Kolczun and Kolczun Orthopaedics. He joined the Staff of Cleveland Clinic in 1999 and has been practicing in the Lorain, Ohio, community since 1992.
Dr. Cann is a frequent lecturer at the local and national level. He is former Associate Professor of Surgical Anatomy at the Ohio College of Podiatric Medicine. In 1994, he was named to the Who's Who of Business and Professionals. Dr. Cann is board-certified in foot and reconstructive rearfoot and ankle surgery by the American College of Podiatric Medicine.
Professional Highlights
- Assistant Director of Podiatric Surgical Residency training, Community Health Partners Regional Medical Center, Lorain, Ohio
Education & Fellowships
| Medical School: | California College of Podiatric Medicine, San Francisco, CA |
|
| Residency: | University of Chicago Hospitals, Chicago, IL |
| Other Education: | (Undergraduate) Oklahoma State University, Stillwater, OK |
Additional Training
- A.O. International Fellowship; Basel, Bern, Switzerland, 1991
- External Rotation: observation of surgical techniques of Dr. Bernard Regnauld, Nantes, France, October 1990
Certifications
Foot Surgery
Reconstructive Rearfoot/Ankle Surgery
Specialty Interests
All nail care, Arthroscopy, diabetic foot management, diabetic footcare with emphasis on foot wound/infection management, diabetic nail & foot care, foot and ankle surgery, foot and ankle trauma, fractures and injuries of the foot and ankle, Heel Pain, podiatry, reconstructive foot and ankle surgery, sports medicine.
Professional Memberships
- Diplomate, American College of Foot and Ankle Surgeons
- American Podiatric Medical Association
- Ohio Podiatric Medical Association
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/29/2009 the review process regarding Dr. Cann’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
